# Hyperinsulinemic Euglycemic Clamp Protocol

> **NCT01408667** · PHASE1,PHASE2 · COMPLETED · sponsor: **Torrent Pharmaceuticals Limited** · enrollment: 40 (actual)

## Conditions studied

- Metabolic Cardiovascular Syndrome

## Interventions

- **DRUG:** TRC150094
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01408667
- **Lead sponsor:** Torrent Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-03
- **Final completion:** —
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408667, "Hyperinsulinemic Euglycemic Clamp Protocol". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01408667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*